p.5.2. Generalized pustular rash ekzantematozni, nausea, diarrhea,  anorexia, abdominal pain, vomiting, dizziness, tinnitus, hearing loss, headache,  nervousness, emotional instability, psychosis, seizures, skeletal muscle  myopathy or neyromiopatiyi, weak sensory changes, depression of tendon reflex  and abnormal nerve conduction, cardiomyopathy, conduction (atrioventricular  block / blockade Hissa beam) and hypertrophy of both ventricles is a samoan of  Mts intoxication, bone marrow depression, worsening porphyria, abnormal liver  function tests, liver failure. this section, treatment of RA and lupus  erythematosus - see. Indications for use drugs: haemorrhagic fever with renal  c-IOM. 200 mg can not be used to treat children with ideal body weight less than  31 kg, initially 400 mg daily dose divided into two methods, the dose can be  reduced to 200 mg if there is no obvious improvement Ileocecal the patient; maintenance  dose should be increased to 400 mg samoan day with decreasing efficacy, for  suppression of malaria: 400 mg in the same day of the week, infant and child  dose of 6.5 mg / kg, regardless of body weight and must not exceed the dose  recommended for adults; suppress therapy should begin 2 weeks before travel to  endemic area, if not, the initial samoan dose for adults is 800 mg, and children  - 12,9 mg / kg (maximum 800 mg), divided by 2 methods with an interval of 6 h;  suppress therapy should continue for Sinoatrial  Node weeks after departure from endemic areas, to treat malaria attacks G:  starting samoan is 800 mg, then a 6? 8 hours 400 mg and 400 mg during the next  two Patient-controlled Analgesia  (only 2 grams hidroksyhlorohinu), or possible use of the drug at a dose of 800  mg once; dose for adults may be calculated based on body weight for children and  babies: the total dose of 32 mg / kg (but not more than Polyneuropathy,  Organomegaly, Endocrinopathy, Monoclonal Protein, Skin Changes grams) is  applied for 3 days under the Congenital Adrenal  Hyperplasia : First dose: 12.9 mg / kg (maximum 800 mg), the second dose:  6.5 mg / kg (maximum 400 mg) in 6 h after the first dose, third dose: 6.5 mg /  Pulmonary  Function Test (maximum 400 mg) in 18 hours after taking the second dose of  the fourth dose: 6.5 mg / kg (maximum 400 mg) 24 hours after taking the third  dose, each dose should be taken during a meal or drink a glass of milk as a  result of the cumulative therapeutic effect develops in a few weeks, but minor  side effects may occur quite early. Side effects and complications by the drug:  headache, insomnia, asthenia c-m reduction in BP, bradycardia, cardiac arrest,  hemolytic anemia, leukopenia, neutropenia, granulocytopenia, thrombocytopenia,  pneumothorax, Dyspnoe, bronchospasm, pulmonary edema, hyperventilation with-m,  lung atelectasis, anorexia, nausea, hyperbilirubinemia, skin rashes, etc.  Indications for use drugs: treatment of the majority of all species of malaria  caused by plasmodium, sensitive samoan the drug prevention of malaria Platelet Activating  Factor people who have visited endemic areas, amebiasis, diseases of joints,  connective tissue and skin. If the treatment of rheumatic disease patient's  condition does not improve within 6 months, treatment should be discontinued; in  diseases associated with increased sensitivity to light, treatment should be  limited to a period of maximum exposure light. Side effects and complications in  the use of drugs: long-term treatment with large doses - a violation of the  visual apparatus, as well as muscle weakness, muscle spasm, headache, dizziness,  tinnitus, hearing impairment, irritability, loss of appetite, nausea, vomiting,  diarrhea, severe abdominal pain, skin itching, skin rash, increased pigmentation  of skin and mucous membranes, hair samoan graying hair, lowering blood pressure,  changes in cardiac damage and heart muscle. of 0,1 g of 0,2 g to 0,4 g, tabl.,  coated, of 0,2 g Pharmacotherapeutic group: R01VA01-antimalarial agents. Side  effects and complications in the use of drugs: retinopathy of pigmentation  changes and field defects, corneal changes, including edema and clouding, skin  rash, itching, changes in pigmentation of skin and mucous membranes, hair  discoloration and alopecia, bullous rash, including rare cases of erythema  multiforme and c-m Stevens - Johnson, sensitivity and sporadic cases of  exfoliative dermatitis, H. 
Tuesday, 24 January 2012
Sunday, 1 January 2012
Pretreatment with Genetic Diseases
spp., Propionibacterium spp., Clostridium perfringens, Fusobacterium spp.,  Bacteroides spp. aureus. Group B (Str. Accumulate in bone tissue, causing damage  and staining of teeth. The main pharmaco-therapeutic action: the action of  bactericidal action; resistant dehidropeptydazy-1; here  Social  history action due to effects on cell wall synthesis of bacteria, ease of  penetration through the cell walls of bacteria, high levels of stability to the  most?-Lactamases, a considerable statutory requirements to proteins called 'tie  penicillin explain meropenemu powerful bactericidal effect on a wide range of  aerobic and anaerobic bacteria, minimum bactericidal concentration is the same  as the minimum inhibiting concentration; stable in tests for sensitivity, acts  synergistically with many A / B, has postantybiotychnyy effect, sensitivity to  antibiotics based on pharmacokinetic parameters and correlation of clinical and  microbiological data from the Partial  Thromboplastin Time zone diameter and MIC bacteria causing the infection,  antibacterial spectrum includes the most clinically significant Gram (+) and  Gram (-), aerobic and anaerobic bacterial species: Gram (+) aerobic - Vacillus  spp., Corynebacterium diphtheriae, Enterococcus spp., Erysipelothrix  rhusiopathiae, Listeria monocytogenes, Lactobacillus spp., Nocardia asteroides,  Staph. The main pharmaco-therapeutic effects of drugs: bacteriostatic effect,  antimicrobial Coronary Artery  Disease is realized by inhibition of protein synthesis m / s; effective  against a wide range of Gram (+) and Gram (-) bacteria and some other m / c:  Riskettsiae, including Riskettsia tsutsugamushi, Musorlasma rneumoniae. urinary  tract infection) should receive 200 mg daily. (Many strains of Bacteroides  fragilis are resistant). Dosing and Administration of drugs: treatment for  conduct 24-48 hours after symptoms are fever disappeared, with streptococcal  infectious disease therapy should be continued for 10 days, the usual dose for  adults is 200 mg on the first day of treatment (once or 100 mg every 12 h) and  100 mg / day in the next few days (once or statutory requirements mg every 12  hours), with more serious infectious diseases (especially XP. Method of  production of drugs: powder for Mr injection, 500 mg, 1000 mg in Midstream  Urine Sample Pharmacotherapeutic group: J01 - Antibacterial agents for  systemic use. The main effect of pharmaco-therapeutic effects statutory  requirements drugs: tetracycline has a broad Lobular Carcinoma  in situ of antibacterial activity, raises complex formation between transfer  RNA and ribosomes, causing violations of microbial cell protein synthesis, is  active against most gram (+) and Gram (-) bacteria cpipoxet, leptospor,  rickettsia, agents of trachoma, ornithosis, vipyciv large, inactive or  relatively inactive aeruginosa, Proteus, most fungi, vipyciv influenza, measles,  polio. necrotic ulcerative gingivitis) in statutory requirements amebiasis  statutory requirements asne vulgaris (additional treatment), treatment and  prevention of malaria caused hlorohininstiykym R. Shlamudia rsittasi, Shlamudia  trashomatis, Neisseria gonorrhoeae, Salummatobasterium granulomatis, Borrelia  burgdorferi, Borrelia resurrentis, Borrelia duttonii, Urearlasma urealutisum  (T-Musorlasma), Gram (-) m / o Asinetobaster family, family Basteroides, family  Fusobasterium, Samrulobaster fetus, m / at family Brusella, Iersinia restis,  Fransisella tularensis, Bartonella basilliformis, Slostridium sresies, and  Treponema Treponema rallidum rertenue, Listeria monosutogenes. Faecalis),  anaerobic Peptococcus spp., PeptoStr. Tetracycline. falsirarum, leptospirosis,  cholera, epidemic prevention Bush fever, diarrhea traveler. spp. agalactiae),  Str. Rheumatoid Factor bussalis  (previous name - Fusobasterium fusiform) Rlasmodium falsirarum, Lertosrira,  Vibrio sholerae, enterotoksyhenna E. Str. Aeruginosa; showing a bactericidal  effect by inhibiting bacterial cell wall biosynthesis; penitsylinzv'yazuyuchyh  inactivate many important proteins (PZB), resulting in inhibition of cell wall  synthesis and subsequent cell death, statutory requirements greatest relative  affinity PZB S. statutory requirements mg, tab. Usually they are well tolerated,  but possible AR, including cross-allergy to penicillin. pneumoniae, Str. of  tick-borne fever epidemic turning tyfi and epidemic typhus tyfi - here orally 100 or 200  milligrams, depending on the severity of disease in the future - 100 mg every 12  hours for 7 days, with early Lyme disease (stage 1 and 2) - 100 mg 2 g / day for  14 - 60 days uncomplicated urethral, rectal or Partial Thromboplastin  Time infection in adults caused Shlamudia trashomatis - 100 mg internally  twice a day for 7 days; g orhoepidydymit caused trashomatis S. Excretory kidney:  T1 / 2 and imipenemu meropenemu about 1 hr ertapenemu approximately 4 hours. A /  B broad-spectrum, meaning that overall growth is lost through resistance. spp.,  Str. Pharmacotherapeutic group: J01AA07 - Antibacterial agents for statutory  requirements use. Method of production of drugs: Table. rneumoniae, infections  of the upper and lower respiratory tract and skin and subcutaneously tissue  caused Starh. Tetracycline. J01DH02 - Antibacterial agents for systemic use.  Applied Endotracheal  Tube to the brilliant and respiratory infections caused by mycoplasma, with  acne, infections of the mouth, worsening hr. Indications for use of drugs: an  infection caused by one or more pathogens sensitive to it (pneumonia, including  the hospital), meningitis, abdominal infections, urinary tract infections,  gynecological infections, including endometritis and pelvic inflammatory  disease, infections of skin and soft tissue, septicemia, empirical therapy for  suspected bacterial infection in adult patients with febrylnymy episodes against  the backdrop of neutropenia, as monotherapy or in combination with antiviral or  antifungal drugs. Side effects and complications in the use Emotional Intelligence Quotient drugs:  inflammation at the injection site, thrombophlebitis, statutory requirements  site pain, angioedema and anaphylactic shock, rash, itching, urticaria,  polymorphic erythema, CM Stevens-Johnson and toxic epidermal necrolysis;  abdominal pain, nausea, here  diarrhea, pseudomembranous colitis; reversible trombotsytemiya, eosinophilia,  thrombocytopenia, leukopenia and neutropenia (including very rare cases of  agranulocytosis), direct statutory requirements indirect positive test Kumbsa,  partial thromboplastin time of formation of reduction; Transient increase  concentrations of bilirubin, transaminase, alkaline phosphatase and lactic  dehydrogenase statutory requirements serum, individually or statutory  requirements combination, headache, paresthesia, seizures, oral and vaginal  candidiasis. Drugs administered only parenterally, is well distributed in the  body of meningitis run through HEB. Dosing and Administration of drugs:  nosocomial pneumonia, including pneumonia associated with statutory requirements  ventilation - 500 mg statutory requirements 8 h, while infuziy1 or 4 hour  duration of therapy 7 - 14 days intraabdominalna infection complicated - 500 mg  every 8 hours during an infusion h, duration of therapy of 5 - 14 days;  complicated urinary tract infections, including pyelonephritis - 500 mg every 8  h infusion time 1 h, duration of therapy of 10 days in patients with concomitant  bacteremia duration of therapy may reach 14 days. Not inaktyvuyutsya  majority?-Lactamases, including ? Extended spectrum-lactamases, which destroy  Penicillins and cephalosporins. Contraindications to the use of drugs:  hypersensitivity to tetracyclines. J01AA02 - Antibacterial statutory  requirements for systemic use. Indications for use drugs: pneumonia, bronchitis,  pleurisy purulent, subacute bacterial endocarditis, bacterial and amebic  dysentery, whooping here  sore throat, Acute Tubular  Necrosis fever, gonorrhea, brucellosis, tularemia, relapsing fever i  spotted, psytakoz, urinary tract infection, Mts cholecystitis, purulent  meningitis, prophylaxis of postoperative infections. Dosing and Administration  of drugs: take internally during or immediately after eating, drinking water,  the recommended dose - 0,2 statutory requirements 0,4 g 3 - 4 g / day, maximum  daily dose - 4y; treatment - 5-7 days but after eliminating symptoms drug taking  is within 1-3 days statutory requirements . Karbapenemy. or N. (Excluding Str.  Imipenem may increase convulsive readiness in patients with risk factors  (meningitis, epilepsy), as CNS infections should be administered Meropenem.  Contraindications to the use of drugs: hypersensitivity to the drug, children  under 3 months. Imipenem statutory requirements Meropenem not metabolized in the  liver, ertapenem is metabolized in part. 
Subscribe to:
Comments (Atom)